Nephrotic livers secrete normal VLDL that acquire structural and functional defects following interaction with HDL

Kidney International

Volumn 65, Issue 1, 2004, Pages 228-237

  Shearer, Gregory C ^b   Couser, William G ^b   Kaysen, George A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

Analbuminemia; Apolipoprotein A I; Apolipoprotein E; Endothelium; Lipolysis; Lipoprotein lipase; Nephrotic syndrome; Proteinuria

Indexed keywords

ALBUMIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN LIPASE; METHIONINE; OLEIC ACID; VERY LOW DENSITY LIPOPROTEIN;

ANALBUMINEMIA; ANIMAL TISSUE; ARTICLE; COCULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; HYPERLIPIDEMIA; INCUBATION TIME; ISOLATED LIVER; LIPOLYSIS; LIVER PERFUSION; NEPHROSIS; NEPHROTIC SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN SECRETION; PROTEIN STRUCTURE; PROTEINURIA; RAT; RAT STRAIN; STRUCTURE ACTIVITY RELATION;

EID: 0347992780     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00373.x     Document Type: Article

References (30)

1. DE SAIN-VAN DER VELDEN MG, KAYSEN GA, DE MEER K, et al: Proportionate increase of fibrinogen and albumin synthesis in nephrotic patients: measurements with stable isotopes. Kidney Int 53:181-188, 1998
2. KAYSEN GA, MEHENDRU L, PAN XM, STAPRANS I: Both peripheral chylomicron catabolism and hepatic uptake of remnants are defective in nephrosis. Am J Physio 263(2 Pt 2):F335-F341, 1992
3. DAVIES RW, STAPRANS I, HUTCHISON FN, KAYSEN GA: Proteinuria, not altered albumin metabolism, affects hyperlipidemia in the nephrotic rat. J Clin Invest 86:600-605, 1990
4. SHEARER GC, STEVENSON FT, ATKINSON DN, et al: Hypoalbuminemia and proteinuria contribute separately to reduced lipoprotein catabolism in the nephrotic syndrome. Kidney Int 59:179-189, 2001
5. SHEARER GC, JOLES JA, JONES H, et al: Estrogen effects on triglyceride metabolism in analbuminemic rats. Kidney Int 57:2268-2274, 2000
6. KAYSEN GA, PAN XM, COUSER WG, STAPRANS I: Defective lipolysis persists in hearts of rats with Heymann nephritis in the absence of nephrotic plasma. Am J Kidney Dis 22:128-134, 1993
7. KAYSEN GA, HOYE E, JONES H JR, et al: Effect of oncotic pressure on apolipoprotein A-I metabolism in the rat. Am J Kidney Dis 26:178-186, 1995
8. SALAM WH, WILCOX HG, HEIMBERG M: Stimulation by oleic acid of incorporation of L-[4,5-3H]leucine into very low density lipoprotein apoprotein by the isolated perfused rat liver. Biochem Biophys Res Commun 132:28-34, 1985
9. SALAM WH, WILCOX HG, HEIMBERG M: Effects of oleic acid on the biosynthesis of lipoprotein apoproteins and distribution into the very-low-density lipoprotein by the isolated perfused rat liver. Biochem J 251:809-316, 1988
10. SCHUMAKER VN, PUPPIONE DL: Sequential flotation ultracentrifugation. Methods Enzymol 128:155-170, 1986
11. EDELSTEIN C, SCANU AM: Precautionary measures for collecting blood destined for lipoprotein isolation. Methods Enzymol 128:151-155, 1986
12. FURUKAWA S, HIRANO T, MAMO JC, et al: Catabolic defect of triglyceride is associated with abnormal very-low-density lipoprotein in experimental nephrosis. Metabolism 39:101-107, 1990
13. DE MAN FH, DE BEER F, VAN DER LAARSE A, et al: Lipolysis of very low density lipoproteins by heparan sulfate proteoglycan-bound lipoprotein lipase. J Lipid Res 38:2465-2472, 1997
14. HELMKAMP RW, CONTRERAS MA, BALE WF: I-131-labeling of proteins by the iodine monochloride method. Int J Appl Radiat Is 18:737-746, 1967
15. DEIGHAN CJ, CASLAKE MJ, MCCONNELL M, et al: Patients with nephrotic-range proteinuria have apolipoprotein C and E deficient VLDL1. Kidney Int 58:1238-1246, 2000
16. SUN X, JONES H JR, JOLES JA, et al: Apolipoprotein gene expression in analbuminemic rats and in rats with Heymann nephritis. Am J Physiol 262:F755-F761, 1992
17. KAYSEN GA, HOYE E, JONES H JR: Apolipoprotein AI levels are increased in part as a consequence of reduced catabolism in nephrotic rats. Am J Physiol 268:F532-F540, 1995
18. BATAL R, TREMBLAY M, BARRETT PH, JACQUES H, et al: Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects. J Lipid Res 41:706-718, 2000
19. BREYER ED, LE NA, LI X, et al: Apolipoprotein C-III displacement of apolipoprotein E from VLDL: Effect of particle size. J Lipid Res 40:1875-1882, 1999
20. KAYSEN GA: Plasma composition in the nephrotic syndrome. Am J Nephrol 13:347-359, 1993
21. VAN TOL A, JANSEN EH, KOOMANS HA, JOLES JA: Hyperlipoproteinemia in Nagase analbuminemic rats: effects of pravastatin on plasma (apo)lipoproteins and lecithin:cholesterol acyltransferase activity. J Lipid Res 32:1719-1728, 1991
22. VAZIRI ND, LIANG K, PARKS JS: Acquired lecithin-cholesterol acyltransferase deficiency in nephrotic syndrome. Am J Physiol Renal Physiol 280:F823-F828, 2001
23. BARTER PJ: Hugh sinclair lecture: the regulation and remodelling of HDL by plasma factors. Atheroscler Suppl 3:39-47, 2002
24. HUANG Y, JI ZS, BRECHT WJ, et al: Overexpression of apolipoprotein E3 in transgenic rabbits causes combined hyperlipidemia by stimulating hepatic VLDL production and impairing VLDL lipolysis. Arterioscler Thromb Vasc Biol 19:2952-2959, 1999
25. HUANG Y, LIU XQ, RALL SC JR, et al: Overexpression and accumulation of apolipoportien E as a cause of hypertrigylceridemia. J of Biol Chem 9:26388-26393, 1998
26. RENSEN PCN, VAN BERKEL TJC: Apolipoprotein E effectively inhibits lipoprotein lipase-mediated lipolysis of chylomicron-like triglycerides rich emulsions in vitro and in vivo. J Biol Chem 271:14791-14799, 1996
27. MCCONATHY WJ, WANG CS: Inhibition of lipoprotein lipase by the receptor-binding domain of apolipoprotein E. FEBS Lett 251:250-252, 1989
28. GOMEZ-CORONADO D, SAEZ GT, LASUNCION MA, HERRERA E: Different hydrolytic efficiencies of adipose tissue lipoprotein lipase on very-low-density lipoprotein subfractions separated by heparin-sepharose chromatography. Biochim Biophys Acta 1167:70-78, 1993
29. ZSIGMOND E, FUKE Y, LI L, et al: Resistance of chylomicron and VLDL remnants to post-heparin lipolysis in ApoE-deficient mice: the role of apoE in lipoprotein lipase-mediated lipolysis in vivo and in vitro. J Lipid Res 39:1852-1861, 1998
30. MEDH JD, FRY GL, BOWEN SL, et al: Lipoprotein lipase-and hepatic triglyceride lipase-promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism. J Lipid Res 41:1858-1871, 2000